Table 1.

Baseline Characteristics of 72 Cases of TB Diagnosed During the First 6 Months of ART and 72 Matched Controls.

	Cases (n=72)	Controls (n=72)	p-value
Gender
Female	42 (58%)	43 (60%)	0.87
Age (Y)
Median (IQR)	36 (29–42)	40 (31–45)	0.13
BMI (kg/m2)
Median (IQR)	19.9 (18.4–21.6)	19.9 (17.5–23.1)	0.23
CD4 Count (cells/uL)
Median (IQR)	106 (43–173)	121 (50–192)	0.14
WHO Clinical Stages
Stage 1	9 (13%)	11 (15%)
Stage 2	20 (28%)	21 (29%)
Stage 3	29 (40%)	27 (38%)
Stage 4	14 (19%)	13 (18%)	0.95
Hemoglobin (g/dL)
Median (IQR)	10.4 (8.3–12.2)	10.0 (9.0–12.9)	0.43
Symptoms
Symptomatic	57 (79%)	13 (18%)	<0.001*
Fever	37 (51%)	9 (13%)	<0.001*
Cough	44 (61%)	7 (10%)	<0.001*
Weight Loss	16 (22%)	5 (7%)	0.009*
Night Sweats	9 (13%)	0	0.002*
Diarrhea	10 (14%)	1 (1%)	0.005*
Signs
Adenopathy	2 (3%)	0	0.15
Ascites	1 (1%)	0	0.32
Outcomes
Death	6 (8%)	2 (3%)	0.15
Lost to Follow-up	3 (4%)	1 (1%)	0.31
Death + Lost	9 (13%)	3 (4%)	0.07

^*Statistically significant by univariate analysis.